2025-09-04 - Analysis Report
Okay, here's a report based on the data you provided, formatted for readability and including analysis:

**Hims & Hers Health Inc (HIMS) Analysis**

Hims & Hers Health Inc is a telehealth company that offers personalized health and wellness solutions.

**1. Performance vs. S&P 500 (VOO)**

*   **HIMS Cumulative Return:** 167.49%
*   **VOO Cumulative Return:** 67.76%
*   **Absolute Divergence:** 97.1 (HIMS outperforms VOO)
*   **Relative Divergence:** 49.2 (Indicates HIMS's performance is in the middle range relative to its historical divergence from VOO)

**Analysis:** HIMS has significantly outperformed the S&P 500 over the observed period. However, the relative divergence suggests its outperformance is not at its historical peak.

**Alpha, Beta Analysis**

| Year       | CAGR     | MDD   | Alpha   | Beta   | Cap(B) |
|------------|----------|-------|---------|--------|--------|
| 2019-2021  | -46.0%   | 51.0% | -84.0%  | -0.0   | 1.5    |
| 2020-2022  | -15.0%   | 72.1% | -17.0%  | -0.0   | 1.4    |
| 2021-2023  | -51.0%   | 72.1% | -69.0%  | -0.1   | 2.0    |
| 2022-2024  | 127.0%  | 78.4% | 101.0%  | -0.1   | 5.5    |
| 2023-2025  | 163.0%  | 80.7% | 111.0%  | -0.1   | 10.2   |

**Analysis:**

*   **CAGR:** HIMS has demonstrated very strong growth in the most recent periods, with a CAGR of 127% and 163% for 2022-2024 and 2023-2025 respectively. However, earlier periods (2019-2023) show negative CAGR values, indicating significant volatility.
*   **MDD:** Maximum Drawdown is consistently high, indicating substantial risk and volatility in HIMS stock.
*   **Alpha:** Alpha is a measure of the investment's performance on a risk-adjusted basis. Positive Alpha values for the most recent periods (101% and 111%) suggest that HIMS has outperformed its benchmark, while negative Alpha values in earlier periods indicate underperformance.
*   **Beta:** Beta values are consistently negative, close to zero, suggesting that the stock's price is not strongly correlated with the overall market (S&P 500). This might be because the company's performance is driven more by company-specific factors than broader market trends.
*   **Cap(B):** The company's market capitalization has grown significantly over the years, from 1.5B to 10.2B, indicating increased investor confidence and market recognition.

**2. Recent Price Action**

*   **Current Price:** 45.02
*   **Last Market Data:** Price: 45.04, Previous Close: 41.53, Change: 8.45
*   **5-Day Moving Average:** 44.17
*   **20-Day Moving Average:** 46.60
*   **60-Day Moving Average:** 51.32

**Analysis:** The stock price saw a significant jump in the last market session, reflected in the 8.45 change. The price is currently below both the 20-day and 60-day moving averages, suggesting a potential short-term downward trend, but above the 5-day moving average, hinting at a possible short-term recovery.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.34 (Low Risk)
*   **RSI:** 42.16 (Neutral, neither overbought nor oversold)
*   **PPO:** -0.34 (Slightly bearish)
*   **Hybrid Signal:** cash_70%_Sell 0.1% of holdings
*   **Delta Previous Relative Divergence (20-day):** -1.0 (Short-term decline)
*   **Expected Return:** -14.5%

**Analysis:**

*   The low MRI suggests a relatively stable market environment for the stock currently.
*   The RSI is neutral, indicating neither strong buying nor selling pressure.
*   The negative PPO suggests the price is below its moving average, indicating a slightly bearish trend.
*   The hybrid signal advises a conservative strategy of maintaining a high cash ratio and slightly selling holdings.
*   The negative change in relative divergence indicates a short-term downward trend compared to its benchmark.
*   The negative expected return indicates potential underperformance relative to the S&P 500 over the long term.

**4. Recent News & Significant Events**

*   **2025-09-02:** Major business developments, regulatory changes, or market events affecting HIMS.
*   **2025-09-01:** Analysts discussing HIMS's recent performance and outlook.
*   **2025-09-03:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-08-31:** Market experts highlighting both risks and opportunities for HIMS.

**Analysis:** Recent news suggests that HIMS is experiencing volatility and is subject to analyst scrutiny due to recent developments, earnings, and market conditions. Investors should stay informed about these factors.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-08-04 | 0.19 | 0.54 B$   |
| 2025-05-05 | 0.22 | 0.59 B$   |
| 2024-11-04 | 0.35 | 0.40 B$   |
| 2024-08-05 | 0.06 | 0.32 B$   |
| 2025-08-04 | 0.06 | 0.32 B$   |

**Analysis:**

*   **EPS:** EPS (Earnings Per Share) values show variability. The most recent EPS is 0.19, while the highest in the table is 0.35 (2024-11-04).
*   **Revenue:** Revenue has generally been increasing over the quarters, with the highest being 0.59 B$ in 2025-05-05.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | $0.54B    | 76.39%        |
| 2025-03-31 | $0.59B    | 73.50%        |
| 2024-12-31 | $0.48B    | 76.81%        |
| 2024-09-30 | $0.40B    | 79.16%        |
| 2024-06-30 | $0.32B    | 81.30%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
|------------|-----------|----------|
| 2025-06-30 | $0.56B    | 7.55%    |
| 2025-03-31 | $0.55B    | 9.01%    |
| 2024-12-31 | $0.48B    | 5.46%    |
| 2024-09-30 | $0.44B    | 17.18%   |
| 2024-06-30 | $0.36B    | 3.67%    |

**Analysis:**

*   **Revenue:** Revenue has generally been increasing, indicating growth.
*   **Profit Margin:** Profit margins are consistently high, suggesting strong operational efficiency.
*   **Equity:** The company's equity has been increasing, indicating financial strength.
*   **ROE:** ROE (Return on Equity) shows variability but generally positive returns, reflecting the company's ability to generate profit from shareholders' investments.

**7. Overall Analysis**

Hims & Hers Health Inc. (HIMS) has shown significant outperformance compared to the S&P 500 in the past, but recent indicators suggest a potential short-term downturn. The company has demonstrated strong revenue growth and high profit margins, indicating a solid business model. However, high historical volatility, recent market volatility, and a negative expected return warrant caution. Recent news and analyst discussions suggest the company is under close scrutiny. The recent jump in price is a positive sign, but it is important to consider the context of recent volatility.

**Recommendation:** Given the mixed signals – strong growth potential versus short-term risks and volatility – a cautious approach is advised. Investors should closely monitor news, earnings, and market conditions before making investment decisions. The hybrid signal recommends a high cash position, indicating a conservative strategy may be prudent.
